Category
70 releases
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and…
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for…
Amgen (NASDAQ: AMGN) today announced financial results for the third quarter of 2026. "Amgen delivered another strong quarter as our strategy for…
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its participation in the 2026 Neuroscience Education Institute (NEI) Fall Congress,…
Nearly nine out of 10 patients experienced a clinical benefit at six months Medtronic receives FDA approval for U.S. labeling update to Symplicity…
New multiplex PCR test simultaneously detects Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic fever viruses in approximately 61 minutes.…
As the First-To-File, Lupin is Eligible for 180-Day Generic Exclusivity MUMBAI, India and NAPLES, Fla., Nov. 3, 2026 — Global pharmaceutical leader…
Cambiotics ApS ("Cambiotics"), the company developing beneficial bacteria designed to support the natural elimination of unwanted compounds, such as…
According to MarketsandMarkets™, the Genotyping Assay Market is projected to reach USD 44.60 billion by 2031 from USD 24.29 billion in 2026, at a…
StimLabs®, a leading regenerative medicine company, today announces the commercial launch of DermaForm™, an FDA 510(k)-cleared porcine-derived…
Culmination of 18 Months of Industry Conversations Delivers Updated Data and New Insights on the Pharma Advertising Landscape— NEW YORK, Nov. 3, 2026…
SignalSpace brings product and trial data into one connected environment, where AI agents dramatically improve data access and analyses so that…
BonV Combines Agentic AI with Forward Deployed Engineers to Bring PhaseV's Vertical Suite of AI Modules into One Connected and Explainable,…
Medrio CTMS, built for small and scaling sponsors and CROs, is available now through the Early Adopter Program ahead of general availability in early…
Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced U.S. FDA clearance of the Access MeMed…
New START site at the IRCCS Istituto Nazionale Tumori Regina Elena will expand access to cancer clinical trials for patients in a major European…
Novel twice-daily extended-release tramadol/paracetamol formulation combines Spektus' proprietary AmyloFlex® technology with GEBRO's established…
Updated BEAM-302 Phase 1/2 Clinical Data Presented at ERS Demonstrated Durable Increases in Functional AAT and Reductions in Mutant Z-AAT; Completion…
Fast Track Designation recognizes the serious unmet medical need in Friedreich's ataxia and is intended to facilitate the development and expedite…
